{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:32:18Z","timestamp":1787142738944,"version":"build-2736575974"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"17","license":[{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Meropenem is a broad-spectrum antimicrobial used to treat a wide variety of pathogens. In clinical practice, meropenem is frequently administered as an extended infusion. However, the stability of meropenem at room temperature when diluted in 0.9% sodium chloride injection (\u201cnormal saline\u201d [NS]) is 1 hour per the package insert. Therefore, the concentration of meropenem during the extended infusion may decline to suboptimal levels due to degradation. The objective of this study was to determine the stability of meropenem diluted in bags of NS and stored at 23-25 \u00b0C.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Meropenem 1-g vials were used to prepare 13 mg\/mL solutions via aseptic compounding that were stored at 23-25 \u00b0C. Samples at 0-, 2-, 4-, 6-, 12-, and 24-hour time points were collected and the meropenem concentration was determined using high-performance liquid chromatography. Data was presented in triplicate measurements of 3 independent drug preparations. Samples were considered stable when the percentage remaining concentration was maintained above the 90% threshold stated in the United States Pharmacopeia-National Formulary monograph.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Chemical stability is typically defined as 90% or more of the drug remaining in the preparation. All sample solutions of meropenem remained above 90% of the initial drug concentration threshold through the 12-hour time point (mean concentration, 92.72%), with a linear decrease in concentration over time. At the 24-hour time point, the remaining concentration of meropenem fell below the 90% threshold (to a mean of 86.65%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Meropenem can remain stable for up to 12 hours when formulated in a polyvinyl chloride bag containing 100 mL of NS stored at 23-25 \u00b0C.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxag103","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:43:07Z","timestamp":1775216587000},"page":"e657-e664","source":"Crossref","is-referenced-by-count":0,"title":["Extended stability of meropenem in 0.9% sodium chloride injection stored at 23-25 \u00b0C"],"prefix":"10.1093","volume":"83","author":[{"given":"Gavin T","family":"Howington","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy , Lexington, KY"},{"name":"Department of Pharmacy Services, University of Kentucky HealthCare , Lexington, KY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Kentucky College of Pharmacy , Lexington, KY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loan","family":"Vu","sequence":"additional","affiliation":[{"name":"University of Kentucky College of Pharmacy , Lexington, KY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Trivedi","sequence":"additional","affiliation":[{"name":"University of Kentucky College of Pharmacy , Lexington, KY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Yang","sequence":"additional","affiliation":[{"name":"University of Kentucky College of Pharmacy , Lexington, KY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William (Bill)","family":"Hankinson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, University of Kentucky HealthCare , Lexington, KY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake T","family":"Barlow","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, University of Kentucky HealthCare , Lexington, KY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E","family":"Prisinzano","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Kentucky College of Pharmacy , Lexington, KY, , Lexington, KY ,","place":["USA"]},{"name":"and Center for Pharmaceutical Research and Innovation, University of Kentucky College of Pharmacy , Lexington, KY, , Lexington, KY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,5]]},"reference":[{"key":"2026081907562646500_zxag103-B1","author":"Meropenem"},{"issue":"8","key":"2026081907562646500_zxag103-B2","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1592\/phco.23.8.988.32878","article-title":"Pharmacokinetics of meropenem 0.5 and 2 g every 8 hours as a 3-hour infusion","volume":"23","author":"Dandekar","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"4","key":"2026081907562646500_zxag103-B3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00134-010-2105-0","article-title":"Optimization of meropenem dosage in the critically ill population based on renal function","volume":"37","author":"Crandon","year":"2011","journal-title":"Intensive Care Med"},{"key":"2026081907562646500_zxag103-B4","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.2147\/DDDT.S212052","article-title":"An investigation of the stability of meropenem in elastomeric infusion devices","volume":"13","author":"Foy","year":"2019","journal-title":"Drug Des Devel Ther"},{"issue":"16","key":"2026081907562646500_zxag103-B5","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/ajhp\/61.16.1682","article-title":"Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device","volume":"61","author":"Smith","year":"2004","journal-title":"Am J Health-Syst Pharm"},{"issue":"1","key":"2026081907562646500_zxag103-B6","doi-asserted-by":"publisher","first-page":"e0206423","DOI":"10.1128\/spectrum.02064-23","article-title":"Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?","volume":"12","author":"Esteban-Cartelle","year":"2024","journal-title":"Microbiol Spectr"},{"issue":"3","key":"2026081907562646500_zxag103-B7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/0018578718779009","article-title":"Stability of meropenem after reconstitution for administration by prolonged infusion","volume":"54","author":"Fawaz","year":"2019","journal-title":"Hosp Pharm"},{"issue":"4","key":"2026081907562646500_zxag103-B8","first-page":"156","article-title":"Stability of meropenem in saline and dextrose solutions and compatibility with potassium chloride","volume":"51","author":"Walker","year":"1998","journal-title":"Can J Hosp Pharm"},{"key":"2026081907562646500_zxag103-B9","doi-asserted-by":"publisher","DOI":"10.31003\/USPNF_M49436_05_01","volume-title":"USP-NF","author":"USP","year":"2020"},{"key":"2026081907562646500_zxag103-B10","volume-title":"USP-NF","author":"USP","year":"2020"},{"issue":"18","key":"2026081907562646500_zxag103-B11","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/ajhp\/zxad132","article-title":"Stability and compatibility study guidelines for AJHP","volume":"80","author":"McPherson","year":"2023","journal-title":"Am J Health-Syst Pharm"},{"issue":"8","key":"2026081907562646500_zxag103-B12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jama.2024.9803","article-title":"Prolonged vs intermittent infusions of \u03b2-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis","volume":"332","author":"Abdul-Aziz","year":"2024","journal-title":"JAMA"},{"issue":"9","key":"2026081907562646500_zxag103-B13","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1093\/jac\/dku150","article-title":"Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study","volume":"69","author":"Feh\u00e9r","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"2026081907562646500_zxag103-B14","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1111\/imj.16584","article-title":"Is it time to implement prolonged infusions of beta-lactam antibiotics in and beyond critical care settings?","volume":"54","author":"Abdul-Aziz","year":"2024","journal-title":"Intern Med J"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag103\/67787375\/zxag103.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/17\/e657\/67787375\/zxag103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/17\/e657\/67787375\/zxag103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:56:34Z","timestamp":1787140594000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/83\/17\/e657\/8586836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,5]]},"references-count":14,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,4,5]]},"published-print":{"date-parts":[[2026,8,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxag103","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,1]]},"published":{"date-parts":[[2026,4,5]]}}}